Semaglutide News and Research

Latest Semaglutide News and Research

GLP-1 drugs found to lower cancer risk in diabetes patients

GLP-1 drugs found to lower cancer risk in diabetes patients

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

Natural compound found in olives can lower blood sugar levels and promote weight loss

Natural compound found in olives can lower blood sugar levels and promote weight loss

New study reveals how GLP-1 receptor agonists enhance preingestive fullness

New study reveals how GLP-1 receptor agonists enhance preingestive fullness

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Study reveals exercise and GLP-1 RA combination preserves bone health during weight loss

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Study finds women lost more of their body weight on average with semaglutide than men

Study finds women lost more of their body weight on average with semaglutide than men

Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes

Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes

New drug tirzepatide significantly improves sleep apnea and weight loss

New drug tirzepatide significantly improves sleep apnea and weight loss

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Semaglutide provides double benefit for women with heart failure

Semaglutide provides double benefit for women with heart failure

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Tirzepatide emerges as first drug therapy for obstructive sleep apnea

Tirzepatide emerges as first drug therapy for obstructive sleep apnea

Semaglutide weight loss results linked to diabetes severity

Semaglutide weight loss results linked to diabetes severity

The USPSTF recommend clinicians refer children and adolescents 6 years or older with a high BMI to intensive behavioral interventions

The USPSTF recommend clinicians refer children and adolescents 6 years or older with a high BMI to intensive behavioral interventions

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

WHO issues medical product alert on falsified semaglutides

WHO issues medical product alert on falsified semaglutides

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.